Table 2

Initial limit of detection results for laboratory developed test (LDT) qPCR assay

2019-nCoV-N1
 Genomes/µL00.371.113.3101001000
 % positive (out of 3)0%67%100%100%100%100%
 Mean Ct
 (SD)
34.8 (0.35)33.14 (0.13)29.89 (0.15)25.99 (0.1)
2019-nCoV-N2
 Genomes/µL00.371.113.3101001000
 % positive (out of 3)33%67%100%100%100%100%
 Mean Ct
 (SD)
40 (0)37.98 (0.51)34.17 (0.31)29.66 (0.21)
RNaseP
 Genomes/µL00.371.113.3101001000
 % positive (out of 3)67%100%100%100%100%100%100%
 Mean Ct
 (SD)
28.01 (0.02)28.0 (0.02)28 (0.02)28 (0.13)28 (0.04)29.01 (0.05)27.96 (0.2)
  • Mean Ct and per cent positivity of a dilution series of samples spiked with in-vitro transcribed RNA of the entire N-gene performed in triplicate are shown for SARS-CoV-2 N1 and N2 targets and a human RNase P control. Concentrations of the IVT RNA dilution series are reported as genomes per microlitre. Results indicate that the lowest concentration at which 100% of samples run in triplicate were detected for both N1 and N2 targets of SARS-CoV-2 genome was 3.3 genomes per microlitre. RNase P primers were used as a positive control to ensure proper specimen collection and monitor against substantial extraction, PCR inhibition, or reagent failure.